Cargando…
High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
Background: Previously published studies have indicated that lymphoid enhancer-binding factor 1 (LEF1) expression could be recognized as a valuable biomarker to evaluate clinical outcome for various types of malignant cancer, but the results remained controversial. Therefore, we conducted this meta-...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468095/ https://www.ncbi.nlm.nih.gov/pubmed/32856045 http://dx.doi.org/10.1042/BSR20202520 |